Usefulness of troponin-I, lactate, C-reactive protein as a prognostic markers in critically ill non-cardiac patients Source: Eur Respir J 2006; 28: Suppl. 50, 181s Year: 2006
C-reactive protein/albumin ratio as a prognostic biomarker in critically ill septic patients: a prospective study Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine Year: 2020
The usefulness of cardiac troponin 1 as a prognostic marker in non cardiac critically ill patients Source: Eur Respir J 2005; 26: Suppl. 49, 522s Year: 2005
Procalcitonin and C-reactive protein levels correlate worse with organ failure than NT-proBNP levels in septic patients Source: Eur Respir J 2006; 28: Suppl. 50, 61s Year: 2006
Usefulness of lactate dehydrogenase and serum C-reactive protein in the follow-up of patients with lung transplantation Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020
Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011
The predictive prognostic role of elevated blood d-dimer and blood lactate in severe sepsis patients Source: Annual Congress 2009 - Acute lung injury and biomarkers Year: 2009
eNAMPT as a novel diagnostic and prognostic biomarker in critically ill septic patients Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers Year: 2018
Admission c-reactive protein and apache II score poorly predict loss of muscle mass in critically ill patients Source: Annual Congress 2009 - Airway management, mechanical ventilation and muscle weakness Year: 2009
Elevated serum high-sensitivity cardiac troponin I is related to mortality in COPD Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018
Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008
Procalcitonin (PCT) and C-reactive protein (CRP) as markers of the differential diagnosis of severe community acquired pneumonia (sCAP) Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013
LATE-BREAKING ABSTRACT: The evolution of procalcitonin as a prognostic factor in critically ill patients with sepsis Source: International Congress 2015 – Acute critical care: novelties in critical care Year: 2015
Effect of serum NT-proBNP and H-FABP levels in predicting extent of acute pulmonary thromboembolism Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010
Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 277s Year: 2004
C-reactive protein (CRP) as a risk marker in COPD patients with ischaemic heart disease Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008
Individual variation in the levels of procalcitonin, neopterin, CRP and MR-proANP during a COPD exacerbation and clinical stable state Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009
Plasma BNP levels as a biomarker of hemodynamic outcome and mortality in cteph following pea Source: Annual Congress 2009 - Acute and chronic venous thromboembolic disease Year: 2009
The relation of serum interleukin-6 and C-reactive protein to clinical parameters in pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 35s Year: 2004
Higher serum C-reactive protein levels predict a worse outcome in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure Source: Eur Respir J 2004; 24: Suppl. 48, 92s Year: 2004